Lobbying

Advamed Imaging's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $240K. Its first report covers Q1 2024; the issues it reports most are Health Issues.

Advamed Imaging

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$240K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2024
The first quarter a report named it

Lobbying by quarter

Advamed Imaging lobbying by quarter
Advamed Imaging lobbying by quarter
QuarterAmountReports
Q1 2024$80K1
Q2 2024$80K1
Q3 2024$80K1
Q4 2024$80K1
Q1 2025$80K1
Q2 2025$80K1
Q3 2025$80K1
Q4 2025$80K1
Q1 2026$80K1
Q2 2026$80K1
Q3 2026$00

By issue

  • Health issues$800K · 10 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE10 reports
  • Executive Office of the President (EOP)3 reports
  • Health & Human Services, Dept of (HHS)3 reports

Firms it paid

Firm
Kountoupes Denham Carr & Reid$800K10 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/08for Q2Kountoupes Denham Carr & Reid$80K
04/09for Q1Kountoupes Denham Carr & Reid$80K
01/14for Q4 2025Kountoupes Denham Carr & Reid$80K
25/10/09for Q3 2025Kountoupes Denham Carr & Reid$80K
25/07/15for Q2 2025Kountoupes Denham Carr & Reid$80K
25/04/14for Q1 2025Kountoupes Denham Carr & Reid$80K
25/01/14for Q4 2024Kountoupes Denham Carr & Reid$80K
24/10/15for Q3 2024Kountoupes Denham Carr & Reid$80K
24/07/15for Q2 2024Kountoupes Denham Carr & Reid$80K
24/04/11for Q1 2024Kountoupes Denham Carr & Reid$80K
24/03/12for Q1 2024Kountoupes Denham Carr & ReidUnder $5,000